Bank of America has published a research report on Eastman Chemical Company EMN and has upgraded the company from Neutral to Buy on a proposed SOA deal.
In the report, Bank of America writes, "Our more constructive posture reflects not only our positive view of Eastman's pending acquisition of Solutia for $4.7bn, or 8.9x trailing EBITDA pre-synergies, but also improved prospects in existing lines, including margin restoration in Eastman's PCI segment and demand recovery elsewhere aided by re-stocking. We consider CEO Jim Rogers to be a savvy steward of shareholder capital and see much to like here including (1) estimated EPS accretion of $0.75 in the first year after expected closure in mid-2012; (2) tax efficiencies based on Solutia's $1.5bn of NOLs; (3) pro forma EBITDA margin accretion of 160bps; (4) potential for slight enhancement to growth rate; and (5) increased exposure to developing
markets."
Bank of America has also raised the price objective from $52 to $64 on Eastman Chemical, which is currently trading up $3.28 from yesterday's $47.12 closing price.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in